|Institutional Source||Beutler Lab|
|Gene Name||ubiquitin protein ligase E3 component n-recognin 1|
|Is this an essential gene?||Probably essential (E-score: 0.757)|
|Stock #||R7121 (G1)|
|Chromosomal Location||120860269-120970715 bp(-) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||G to A at 120875498 bp|
|Amino Acid Change||Leucine to Phenylalanine at position 1495 (L1495F)|
|Ref Sequence||ENSEMBL: ENSMUSP00000028728 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000028728]|
|Predicted Effect||probably benign
AA Change: L1495F
PolyPhen 2 Score 0.004 (Sensitivity: 0.98; Specificity: 0.59)
AA Change: L1495F
|Coding Region Coverage||
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The N-end rule pathway is one proteolytic pathway of the ubiquitin system. The recognition component of this pathway, encoded by this gene, binds to a destabilizing N-terminal residue of a substrate protein and participates in the formation of a substrate-linked multiubiquitin chain. This leads to the eventual degradation of the substrate protein. The protein described in this record has a RING-type zinc finger and a UBR-type zinc finger. Mutations in this gene have been associated with Johanson-Blizzard syndrome. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous null mutants have 20% lower body weight and reduced muscle and adipose tissue. Skeletal muscle lacks a mechanism for targeting proteins for rapid catabolism. Aberrant regulation of fatty acid synthase upon starvation is also observed. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Ubr1||
(F):5'- ACAAGTCTCCATTCGCTGTC -3'
(R):5'- TTTTCAAAGTCTCCCTGGTAGAGG -3'
(F):5'- CCATTCGCTGTCTGATTTCAG -3'
(R):5'- AGCCCTTGGAGAGTCTTTGCC -3'